For the year ending 2025-12-31, CORT has $836,651K in assets. $188,846K in debts. $120,495K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 120,495 | |||
| Short-term marketable securities | 251,657 | |||
| Trade receivables, net of allowances | 59,786 | |||
| Inventory | 12,868 | |||
| Prepaid expenses and other current assets | 40,658 | |||
| Total current assets | 485,464 | |||
| Strategic inventory | 11,094 | |||
| Operating lease right-of-use asset | 4,583 | |||
| Property and equipment, net | 1,890 | |||
| Long-term marketable securities | 160,270 | |||
| Other assets | 5,153 | |||
| Deferred tax assets, net | 168,197 | |||
| Total assets | 836,651 | |||
| Accounts payable | 40,444 | |||
| Accrued research and development expenses | 33,954 | |||
| Accrued and other liabilities | 90,603 | |||
| Short-term operating lease liability | 1,084 | |||
| Total current liabilities | 166,085 | |||
| Long-term operating lease liability | 5,023 | |||
| Long-term accrued government rebates | 2,562 | |||
| Long-term accrued income taxes payable | 15,176 | |||
| Total liabilities | 188,846 | |||
| Common stock, par value 0.001 per share, 280,000 shares authorized and 142,518 issued and 105,966 outstanding as of december31, 2025 and 137,753 shares issued and 105,113 outstanding as of december31, 2024 | 140 | |||
| Treasury stock at cost 36,552 shares of common stock as of december31, 2025 and 32,640 shares of common stock as of december31, 2024 | 966,586 | |||
| Additional paid-in capital | 968,600 | |||
| Accumulated other comprehensive income (loss) | 2,264 | |||
| Retained earnings | 643,387 | |||
| Total stockholders equity | 647,805 | |||
| Total liabilities and stockholders equity | 836,651 | |||
CORCEPT THERAPEUTICS INC (CORT)
CORCEPT THERAPEUTICS INC (CORT)